Observational studyCancer immunology, immunotherapy : CII2025

Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients.

Linling Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.